ADRENOCORTICAL CARCINOMA
Clinical trials for ADRENOCORTICAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADRENOCORTICAL CARCINOMA trials appear
Sign up with your email to follow new studies for ADRENOCORTICAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Radioactive cancer drug trial halted early
Disease control TerminatedThis study tested a radioactive drug called [225Ac]-FPI-1434 in people with advanced solid tumours that had not responded to standard treatments. The goal was to find a safe dose and see if it could shrink tumours. The trial was stopped early, so results are limited. Participants…
Matched conditions: ADRENOCORTICAL CARCINOMA
Phase: PHASE1 • Sponsor: Fusion Pharmaceuticals Inc. • Aim: Disease control
Last updated May 26, 2026 04:18 UTC
-
Experimental vaccine trial for rare adrenal cancers halted early
Disease control TerminatedThis early-stage trial tested a new therapeutic vaccine (EO2401) combined with immune-boosting drugs in 70 people with advanced adrenal gland cancers (adrenocortical carcinoma or malignant pheochromocytoma/paraganglioma). The goal was to see if the combination was safe and could …
Matched conditions: ADRENOCORTICAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Enterome • Aim: Disease control
Last updated May 26, 2026 04:14 UTC